CLINICAL_TRIALS
research
· 2025-12-16
Clinical Trial Update: The GENPET Study - An Imaging Study of FCH-PET-CT in Men With Prostate Cancer and a DNA Repair Gene Mutation.
Summary
The GENPET study is a recruiting imaging trial evaluating FCH-PET-CT in men with prostate cancer who carry DNA repair gene mutations.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Institute of Cancer Research, United Kingdom | Conditions: Prostate Cancer, BRCA Mutation | Status: RECRUITING